N-Methylation of Aromatic Amines and N-Heterocycles under Acidic Conditions with the TTT (1,3,5-Trioxane–Triethylsilane–Trifluoroacetic Acid) System

Abstract

A novel reductive N-methylation protocol under acidic conditions with the TTT (1,3,5-trioxane–triethylsilane–trifluoroacetic acid) system is disclosed. This method is highly specific for aromatic amines and several N-heterocycles (indoles and annulated analogues, phenoxazine, phenothiazine), insensitive to steric hindrance, and compatible with a wide range of functional groups. Further the N-methylation step can be combined with an in situ N-Boc deprotection. Compounds in which the nucleophilicity of the NH group is eliminated by protonation under the reaction conditions (aliphatic amines, azaarenes of noteworthy basicity) are inert. In several examples, it was demonstrated that the TTT system is complementary to other N-methylation protocols.

Key words

N-methylation - aromatic amines - heterocycles - chemoselectivity - triethylsilane - trioxane

• References

• 1 Jiang X, Tiwari A, Thompson M, Chen Z, Cleary TP, Lee TB. K. Org. Process Res. Dev. 2001; 5: 604
• 2 Honarnejad K, Daschner A, Gehring A, Szybinska A, Giese A, Kuznicki J, Bracher F, Herms J. Transl. Psychiatry 2014; 4: e489
• 3a Shieh W.-C, Dell S, Bach A, Repic O, Blacklock TJ. J. Org. Chem. 2003; 68: 1954
• 3b Ouk S, Thiébaud S, Borredon E. Synth. Commun. 2005; 35: 3021
• 3c Selva M, Tundo P, Brunelli D, Perosa A. Green Chem. 2007; 9: 463
• 4 Clarke HT, Gillespie HB, Weisshaus SZ. J. Am. Chem. Soc. 1933; 55: 4571
• 5a Sondengam BL, Hémo JH, Charles G. Tetrahedron Lett. 1973; 14: 261
• 5b Bhattacharyya S. Synth. Commun. 1995; 25: 2061
• 6 Borch RF, Hassid AI. J. Org. Chem. 1972; 37: 1673
• 7 Kim S, Oh CH, Ko JS, Ahn KH, Kim YJ. J. Org. Chem. 1985; 50: 1927
• 8 Gribble GW, Nutaitis CF. Synthesis 1987; 709
• 9 Jung YJ, Bae JW, Yoon C.-OM, Yoo BW, Yoon CM. Synth. Commun. 2001; 31: 3417
• 10 Castro JL, Baker R, Guiblin AR, Hobbs SC, Jenkins MR, Russel MG. N, Beer MS, Stanton JA, Scholey K, Hargreaves RJ, Graham MI, Matassa VG. J. Med. Chem. 1994; 37: 3023
• 11a Horner JK, Skinner WA. Can. J. Chem. 1966; 44: 315
• 11b Ram S, Ehrenkaufer RE. Tetrahedron Lett. 1985; 26: 5367
• 12a Stanovnik B, Tisler M, Hribar A, Barlin GB, Brown DJ. Austr. J. Chem. 1981; 34: 1729
• 12b Middleton RW, Monney H, Parrick J. Synthesis 1984; 740
• 13a Pohl B, Luchterhandt T, Bracher F. Synth. Commun. 2007; 37: 1273
• 13b Fedorov O, Huber K, Eisenreich A, Filippakopoulos P, King O, Bullock AN, Fabro D, Trappe J, Rauch U, Bracher F, Knapp S. Chem. Biol. 2011; 18: 67
• 13c Huber K, Brault L, Fedorov O, Gasser C, Filippakopoulos P, Bullock AN, Fabbro D, Trappe J, Schwaller J, Knapp S, Bracher F. J. Med. Chem. 2012; 55: 403
• 13d Strödke B, Gehring AP, Bracher F. Arch. Pharm. Chem. Life Sci. 2015; 348: 125
• 14 Righi M, Bedini A, Piersanti G, Romagnoli F, Spadoni G. J. Org. Chem. 2011; 76: 704
• 15a Patel JP, Li A.-H, Dong H, Korlipara VL, Mulvihill MJ. Tetrahedron Lett. 2009; 50: 5975
• 15b Park ES, Lee JH, Kim SJ, Yoon CM. Synth. Commun. 2003; 33: 3387
• 16 Righi M, Topi F, Bartolucci S, Bedini A, Piersanti G, Spadoni G. J. Org. Chem. 2012; 77: 6351
• 17 Sokol H, Heights H. US Patent 2465489 A, 1949 ; Chem. Abstr. 1949, 43, 5809i.
• 18 Pews RG, Hunter JE, Wehmeyer RM. Tetrahedron 1993; 49: 4809
• 19 Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP. J. Am. Chem. Soc. 2010; 132: 10842
• 20a Lanzilotti AE, Littell R, Fanshawe WJ, McKenzie TC, Lovell FM. J. Org. Chem. 1979; 44: 4809
• 20b Pearson DA, Blanchette M, Baker ML, Guindon CA. Tetrahedron Lett. 1989; 30: 2739
• 21 Chen MZ, Micalizio GC. Org. Lett. 2009; 11: 4982
• 22 Bracher F, Hildebrand D. Liebigs Ann. Chem. 1992; 1315
• 23 Bracher F, Hildebrand D. Arch. Pharm. (Weinheim) 1992; 325: 645
• 24 Mehta A, Jaouhari R, Benson TJ, Douglas KT. Tetrahedron Lett. 1992; 33: 5441
• 25 Diep V, Dannenberg JJ, Franck RW. J. Org. Chem. 2003; 68: 7907